DDDIX
Price
$23.13
Change
-$0.03 (-0.13%)
Updated
Nov 13 closing price
FSMAX
Price
$94.79
Change
-$0.65 (-0.68%)
Updated
Nov 13 closing price
Ad is loading...

DDDIX vs FSMAX

Header iconDDDIX vs FSMAX Comparison
Open Charts DDDIX vs FSMAXBanner chart's image
13D Activist I
Price$23.13
Change-$0.03 (-0.13%)
VolumeN/A
CapitalizationN/A
Fidelity Extended Market Index
Price$94.79
Change-$0.65 (-0.68%)
VolumeN/A
CapitalizationN/A
DDDIX vs FSMAX Comparison Chart
Loading...
View a ticker or compare two or three
VS
DDDIX vs. FSMAX commentary
Nov 14, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is DDDIX is a StrongBuy and FSMAX is a Buy.

FUNDAMENTALS
Fundamentals
FSMAX has more cash in the bank: 40B vs. DDDIX (146M). FSMAX pays higher dividends than DDDIX: FSMAX (1.10) vs DDDIX (0.00). DDDIX was incepted earlier than FSMAX: DDDIX (13 years) vs FSMAX (13 years). DDDIX is a more actively managed with annual turnover of: 91.00 vs. FSMAX (18.00). FSMAX has a lower initial minimum investment than DDDIX: FSMAX (0) vs DDDIX (1000000). FSMAX annual gain was more profitable for investors over the last year : 44.46 vs. DDDIX (21.07). FSMAX return over 5 years is better than : 56.97 vs. DDDIX (6.53).
DDDIXFSMAXDDDIX / FSMAX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence13 years13 years-
Gain YTD6.19022.26528%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets146M40B0%
Annual Yield % from dividends0.001.10-
Returns for 1 year21.0744.4647%
Returns for 3 years-22.263.44-648%
Returns for 5 years6.5356.9711%
Returns for 10 years36.4787.6242%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MTN182.390.57
+0.31%
Vail Resorts
AGX154.14-3.01
-1.92%
Argan
NVRO5.06-0.26
-4.89%
NEVRO Corp
TIRX1.71-0.09
-5.00%
TIAN RUIXIANG Holdings Ltd
ETON9.15-0.56
-5.77%
Eton Pharmaceuticals